BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 8.10.2015

Integrated Summary of Effectiveness; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a guidance for industry entitled "Integrated Summary of Effectiveness." This guidance describes how an integrated summary of effectiveness (ISE) should be prepared by industry for new drug applications (NDAs) and biologics license applications (BLAs). This guidance is intended to improve the quality of drug applications by describing what efficacy information should be submitted so that FDA can make a regulatory decision on an application. This guidance finalizes the draft guidance issued August 28, 2008.

Source: Federal Register — Food and Drug AdministrationOpen original release →